Evidence map›Paper›PMID 38272861›Full record

ArticleCell death discovery2024

Uveitic glaucoma-like features in Yap conditional knockout mice.

Juliette Bitard, Elodie-Kim Grellier, Sophie Lourdel, Helena Prior Filipe, Annaïg Hamon, François Fenaille, Florence Anne Castelli, Emeline Chu-Van, Jérôme E Roger, Morgane Locker and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Juliette BitardUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France. juliette.bitard@universite-paris-saclay.fr.ORCID http://orcid.org/0000-0001-6626-3522
Elodie-Kim GrellierUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France.
Sophie LourdelUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France.
Helena Prior FilipeWest Lisbon Hospitals Center, Hospital de Egas Moniz, Lisbon, Portugal.
Annaïg HamonUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France.
François FenailleUniversité Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), MetaboHUB, Gif sur Yvette, France.ORCID http://orcid.org/0000-0001-6787-4149
Florence Anne CastelliUniversité Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), MetaboHUB, Gif sur Yvette, France.
Emeline Chu-VanUniversité Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), MetaboHUB, Gif sur Yvette, France.
Jérôme E RogerUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France.ORCID http://orcid.org/0000-0002-5061-230X
Morgane LockerUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France.
Muriel PerronUniversité Paris-Saclay, CNRS, Institut des Neurosciences Paris-Saclay, Saclay, France. muriel.perron@universite-paris-saclay.fr.ORCID http://orcid.org/0000-0002-1558-8236
Centre National de la Recherche Scientifique · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRHospital de Egas Moniz · PT

Funding

Fondation de France n/a
6 · The paper itself

Abstract

Glaucoma is a multifactorial neurodegenerative disease characterized by the progressive and irreversible degeneration of the optic nerve and retinal ganglion cells. Despite medical advances aiming at slowing degeneration, around 40% of treated glaucomatous patients will undergo vision loss. It is thus of utmost importance to have a better understanding of the disease and to investigate more deeply its early causes. The transcriptional coactivator YAP, an important regulator of eye homeostasis, has recently drawn attention in the glaucoma research field. Here we show that Yap conditional knockout mice (Yap cKO), in which the deletion of Yap is induced in both Müller glia (i.e. the only retinal YAP-expressing cells) and the non-pigmented epithelial cells of the ciliary body, exhibit a breakdown of the aqueous-blood barrier, accompanied by a progressive collapse of the ciliary body. A similar phenotype is observed in human samples that we obtained from patients presenting with uveitis. In addition, aged Yap cKO mice harbor glaucoma-like features, including deregulation of key homeostatic Müller-derived proteins, retinal vascular defects, optic nerve degeneration and retinal ganglion cell death. Finally, transcriptomic analysis of Yap cKO retinas pointed to early-deregulated genes involved in extracellular matrix organization potentially underlying the onset and/or progression of the observed phenotype. Together, our findings reveal the essential role of YAP in preserving the integrity of the ciliary body and retinal ganglion cells, thereby preventing the onset of uveitic glaucoma-like features.

Identifiers

PMID38272861
PMCPMC10811226
OpenAlexW4391222687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.